A carregar...
To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone
The recently published phase II prospective SWITCH trial evaluated whether patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate could benefit from a ‘steroid switch’ from prednisone to dexamethasone. A total of 26 patients, both chemonaïve (14 patien...
Na minha lista:
| Publicado no: | Ther Adv Urol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6560791/ https://ncbi.nlm.nih.gov/pubmed/31217821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287219854908 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|